Latest Posts
About This Stock
More About This Stock
Read
Read
Read
S The Sunday File For Nov. 21

Article By:
Vivian Lewis
Sunday, November 21, 2021 7:21 PM EDT
Good news and bad - making up for the short week by getting a Sunday start.
Here's My Top Value Stock To Buy Right Now

Article By:
StockNews
Monday, November 1, 2021 8:53 AM EDT
EXEL is working on further expanding cabozantinib’s label. It is currently evaluating the drug as a single agent and in combination with immune checkpoint inhibitors across various indications.
Calithera Biosciences: An Under The Radar Opportunity

Article By:
StockMatusow
Monday, December 7, 2020 5:30 AM EDT
Calithera is a high-risk, high reward speculative investment addressing high unmet and under-served needs markets, with a lower bar data threshold to meet. Calithera has an important near-term catalyst shortly upcoming.